Global 3D Printing Medical Device Software Market Forecast till 2027

$4,450$6,250

the global 3D printing medical device software market is expected to exhibit a notable CAGR of 17.62% during the review period of 2020 to 2027.

Clear

Description

Global 3D Printing Medical Device Software Market Forecast till 2027
Market Overview
According to CRI, the global 3D printing medical device software market is expected to exhibit a notable CAGR of 17.62% during the review period of 2020 to 2027. 3D printing is emerging as a permissive technology for various unfold applications and the global market is anticipated to push the growth. Nowadays the technology is endorsed into the healthcare sector enabling 3D printing applications for medical practitioners, manufacturers of medical devices, as well as researchers in drug development and safety, dental & orthodontic treatments, etc. The technology is adopted rapidly as it helps patient engagement in understanding their diseases and participating in their decision-making and improves communication with patients. The market growth of global 3D printing is attributed to the growing public-private funding for 3D Printing development and technology up-gradation in recent years.
The global 3D printing market is expected to witness healthy market growth with the highest market value of USD 657.08 million in 2019. The global market growth is attributed to the technological developments in a software solution growing demand for low-cost 3D printed medical devices and the increasing need for customized medical devices. However, Stringent government regulations for the approval of 3D-printed medical devices are expected to restrain the global market growth during the review period.

Market Segmentation
The global 3D printing medical device software market is segmented into type, function, application, and end-user.
Based on the Type segment the global market has been bifurcated into Integrated and Standalone.
In terms of function the Global 3D Printing Medical Device Software Market has been classified into Printing, Analysis, Planning, Design, Visualization, Navigation, and Others.
In terms of the Application segment, the market has been classified into Medical Imaging, Dental, Surgery, Research, Physical Therapy, Aesthetic Medicine, and Others.
Based on End Users the global market is segmented into Medical Device Companies, Dental Laboratories, Hospitals and Clinics, Research Institutes, and Others.
Regional Analysis
The global 3D printing medical devices software market has been studied across the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The Americas is likely to drive the global market owing to the 42.16% market share in 2019. The regional market is driven by the innovation & fastest adoption of advanced technologies and the existence of major players in this region. For instance, key leaders, including Materialise (Belgium) and Stratasys (Israel), have a presence in the region.
Europe is expected to contribute the second-largest market in the 3D printing medical devices software market due to innovations in technology and a well-established medical industry in the region. Germany, the UK, Italy, and France are the leading 3D printing medical device software markets.
Major Players
The prominent players in the global 3D printing medical device software market include Stratasys Ltd (Israel), Nemotec (Italy), ), Real Dimension Inc (US), Regenhu (Switzerland), 3D Totem (Israel), Ackuretta Technologies (China), PS-Medtech (Netherlands), DWS Systems (Italy), 3D Systems Corporation (US), Carima (South Koreaand Materialise NV (Belgium).

COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

Additional information

Publisher

Geography Covered

Date Published

Pages

Format

Table of Contents

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY 13

2 MARKET INTRODUCTION 16

2.1 DEFINITION 16

2.2 SCOPE OF THE STUDY 16

2.3 RESEARCH OBJECTIVE 16

2.4 MARKET STRUCTURE 17

2.5 ASSUMPTIONS & LIMITATIONS 17

3 RESEARCH METHODOLOGY 18

3.1 DATA MINING 18

3.2 SECONDARY RESEARCH 19

3.3 PRIMARY RESEARCH 19

3.4 BREAKDOWN OF PRIMARY RESPONDENTS 20

3.5 FORECASTING TECHNIQUES 21

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 22

3.6.1 BOTTOM-UP APPROACH 23

3.6.2 TOP-DOWN APPROACH 23

3.7 DATA TRIANGULATION 24

3.8 VALIDATION 24

4 MARKET DYNAMICS 25

4.1 OVERVIEW 25

4.2 DRIVERS 26

4.2.1 ONGOING TECHNOLOGICAL ADVANCEMENTS IN SOFTWARE SOLUTIONS 26

4.2.2 INCREASING DEMAND FOR LOW-COST 3D PRINTED MEDICAL DEVICES 26

4.2.3 RISING DEMAND FOR CUSTOMIZED MEDICAL DEVICES 26

4.3 RESTRAINTS 27

4.3.1 STRINGENT REGULATORY GUIDELINES FOR THE APPROVAL OF 3D-PRINTED MEDICAL DEVICES 27

4.3.2 LIMITATION IN MATERIALS FOR 3D PRINTING 27

4.4 OPPORTUNITIES 28

4.4.1 DIRECT DIGITAL MANUFACTURING 28

4.4.2 INCREASING DEMAND IN DENTAL INDUSTRY 28

5 MARKET FACTOR ANALYSIS 29

5.1 SUPPLY CHAIN ANALYSIS 29

5.1.1 PLANNING 30

5.1.2 SOURCING 30

5.1.3 DISTRIBUTION & SALES 30

5.1.4 POST-SALES REVIEW/MAINTAINING 30

5.2 PORTER’S FIVE FORCES MODEL 31

5.2.1 THREAT OF NEW ENTRANTS 32

5.2.2 BARGAINING POWER OF SUPPLIERS 32

5.2.3 BARGAINING POWER OF BUYERS 32

5.2.4 INTENSITY OF RIVALRY 32

5.3 IMPACT OF COVID-19 32

5.3.1 OVERVIEW 32

5.3.2 IMPACT ON 3D PRINTING MEDICAL DEVICE SOFTWARE 33

6 GLOBAL 3D PRINTING MEDICAL DEVICE SOFTWARE MARKET, BY TYPE 34

6.1 OVERVIEW 34

6.2 INTEGRATED 35

6.3 STANDALONE 35

7 GLOBAL 3D PRINTING MEDICAL DEVICE SOFTWARE MARKET, BY FUNCTION 36

7.1 OVERVIEW 36

7.2 PRINTING 37

7.3 ANALYSIS 37

7.4 PLANNING 38

7.5 DESIGN 38

7.6 VISUALIZATION 39

7.7 NAVIGATION 39

7.8 OTHERS 39

8 GLOBAL 3D PRINTING MEDICAL DEVICE SOFTWARE MARKET, BY APPLICATION 40

8.1 OVERVIEW 40

8.2 MEDICAL IMAGING 41

8.3 DENTAL 41

8.4 SURGERY 42

8.5 RESEARCH 42

8.6 PHYSICAL THERAPY 43

8.7 AESTHETIC MEDICINE 43

8.8 OTHERS 44

9 GLOBAL 3D PRINTING MEDICAL DEVICE SOFTWARE MARKET, BY END USER 45

9.1 OVERVIEW 45

9.2 MEDICAL DEVICE COMPANIES 46

9.3 DENTAL LABORATORIES 46

9.4 HOSPITALS AND CLINICS 47

9.5 RESEARCH INSTITUTES 47

9.6 OTHERS 48

10 GLOBAL 3D PRINTING MEDICAL DEVICE SOFTWARE MARKET, BY REGION 49

10.1 OVERVIEW 49

10.2 AMERICAS 51

10.2.1 NORTH AMERICA 54

10.2.1.1 US 56

10.2.1.2 CANADA 57

10.2.2 LATIN AMERICA 59

10.3 EUROPE 62

10.3.1 WESTERN EUROPE 64

10.3.1.1 GERMANY 67

10.3.1.2 FRANCE 69

10.3.1.3 UK 71

10.3.1.4 ITALY 72

10.3.1.5 SPAIN 74

10.3.1.6 REST OF WESTERN EUROPE 76

10.3.2 EASTERN EUROPE 78

10.4 ASIA-PACIFIC 80

10.4.1 CHINA 83

10.4.2 JAPAN 85

10.4.3 INDIA 87

10.4.4 AUSTRALIA 88

10.4.5 SOUTH KOREA 90

10.4.6 REST OF ASIA-PACIFIC 92

10.5 MIDDLE EAST & AFRICA 95

10.5.1 MIDDLE EAST 97

10.5.2 AFRICA 99

11 COMPETITIVE LANDSCAPE 102

11.1 OVERVIEW 102

11.2 COMPETITIVE BENCHMARKING 103

11.3 GLOBAL 3D PRINTING MEDICAL DEVICE SOFTWARE MARKET: COMPANY RANKING, 2019 104

11.4 MAJOR GROWTH STRATEGY IN THE GLOBAL 3D PRINTING MEDICAL DEVICE SOFTWARE MARKET 104

11.5 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS 105

11.6 COMPETITIVE BENCHMARKING: GLOBAL 3D PRINTING MEDICAL DEVICE SOFTWARE MARKET 105

11.7 KEY DEVELOPMENTS & GROWTH STRATEGIES 106

11.7.1 PRODUCT APPROVALS AND LAUNCHES 106

11.7.2 ACQUISITIONS 107

11.8 FINANCIAL MATRIX 107

12 COMPANY PROFILES 108

12.1 STRATASYS LTD 108

12.1.1 COMPANY OVERVIEW 108

12.1.2 FINANCIAL OVERVIEW 109

12.1.3 PRODUCTS/SERVICES OFFERED 110

12.1.4 KEY DEVELOPMENTS 111

12.1.5 SWOT ANALYSIS 111

12.1.6 KEY STRATEGIES 111

12.2 NEMOTEC 112

12.2.1 COMPANY OVERVIEW 112

12.2.2 FINANCIAL OVERVIEW 112

12.2.3 PRODUCTS/SERVICES OFFERED 112

12.2.4 KEY DEVELOPMENTS 113

12.2.5 SWOT ANALYSIS 113

12.2.6 KEY STRATEGIES 113

12.3 PS-MEDTECH 114

12.3.1 COMPANY OVERVIEW 114

12.3.2 FINANCIAL OVERVIEW 114

12.3.3 PRODUCTS/SERVICES OFFERED 114

12.3.4 KEY DEVELOPMENTS 114

12.3.5 SWOT ANALYSIS 115

12.3.6 KEY STRATEGIES 115

12.4 DWS SYSTEMS 116

12.4.1 COMPANY OVERVIEW 116

12.4.2 FINANCIAL OVERVIEW 116

12.4.3 PRODUCTS/SERVICES OFFERED 116

12.4.4 KEY DEVELOPMENTS 117

12.4.5 SWOT ANALYSIS 118

12.4.6 KEY STRATEGIES 118

12.5 3D SYSTEMS CORPORATION 119

12.5.1 COMPANY OVERVIEW 119

12.5.2 FINANCIAL OVERVIEW 120

12.5.3 PRODUCTS/SERVICES OFFERED 121

12.5.4 KEY DEVELOPMENTS 123

12.5.5 SWOT ANALYSIS 124

12.5.6 KEY STRATEGIES 124

12.6 CARIMA 125

12.6.1 COMPANY OVERVIEW 125

12.6.2 FINANCIAL OVERVIEW 125

12.6.3 PRODUCTS/SERVICES OFFERED 125

12.6.4 KEY DEVELOPMENTS 126

12.6.5 SWOT ANALYSIS 126

12.6.6 KEY STRATEGIES 126

12.7 REAL DIMENSION INC. 127

12.7.1 COMPANY OVERVIEW 127

12.7.2 FINANCIAL OVERVIEW 127

12.7.3 PRODUCTS/SERVICES OFFERED 127

12.7.4 KEY DEVELOPMENTS 127

12.7.5 SWOT ANALYSIS 128

12.7.6 KEY STRATEGIES 128

12.8 REGENHU 129

12.8.1 COMPANY OVERVIEW 129

12.8.2 FINANCIAL OVERVIEW 129

12.8.3 PRODUCTS/SERVICES OFFERED 129

12.8.4 KEY DEVELOPMENTS 129

12.8.5 SWOT ANALYSIS 130

12.8.6 KEY STRATEGIES 130

12.9 3D TOTEM 131

12.9.1 COMPANY OVERVIEW 131

12.9.2 FINANCIAL OVERVIEW 131

12.9.3 PRODUCTS/SERVICES OFFERED 131

12.9.4 KEY DEVELOPMENTS 131

12.9.5 SWOT ANALYSIS 132

12.9.6 KEY STRATEGIES 132

12.10 ACKURETTA TECHNOLOGIES 133

12.10.1 COMPANY OVERVIEW 133

12.10.2 FINANCIAL OVERVIEW 133

12.10.3 PRODUCTS/SERVICES OFFERED 133

12.10.4 SWOT ANALYSIS 134

12.10.5 KEY STRATEGIES 134

12.11 MATERIALISE NV 135

12.11.1 COMPANY OVERVIEW 135

12.11.2 FINANCIAL OVERVIEW 136

12.11.3 PRODUCTS/SERVICES OFFERED 137

12.11.4 KEY DEVELOPMENTS 137

12.11.5 SWOT ANALYSIS 138

12.11.6 KEY STRATEGIES 138

13 APPENDIX 139

13.1 REFERENCES 139

13.2 RELATED REPORTS 139